1Cullinan SA,Moertel C G,Fleming T R,et al.A comparison of three chemotherapentic regimens in the treatment of advanced pancreatic and gatric carcinoma.JAMA,1985,253(4):2061-2067.
6Adjek AA,Argiris,Murren JR.Docetaxel and iri note cacer.alone and in combination,in the treatment of nonsmall cell lung cancer.Semin Oncol,1999,26 (Suppl 16):32-40.
7Adachi,Watanabe T,Takashima S,et al.A Late phase Ⅰ study of RP56976 (docetaxel) in patients with advanced or recureent breast cancer.Br J Cancer,1995,73 (2):210-216.
8Morales S,Lorenzo A,Ramos M,et al.Docetaxel plus epirubicin is a highly active,well-tolerated,first-line chemotherapy for metastatic breast cancer:results of a large,multicentre phase Ⅱ study.Cancer Chemother Pharmacol,2004,53 (1):75-81.
